PREDICTING PATHOLOGICAL STAGE OF LOCALIZED PROSTATE CANCER USING VOLUME WEIGHTED MEAN NUCLEAR VOLUME
- 1 November 2000
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 164 (5) , 1587-1590
- https://doi.org/10.1016/s0022-5347(05)67034-6
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional updatePublished by American Medical Association (AMA) ,1997
- Role of Volume Weighted Mean Nuclear Volume for Predicting Disease Outcome in Patients with Renal Cell CarcinomaJournal of Urology, 1997
- Control of Prostate Cancer with Radiotherapy: Long-Term ResultsJournal of Urology, 1994
- Prostate cancer kills: Strategy to reduce deathsUrology, 1994
- Results of Conservative Management of Clinically Localized Prostate CancerNew England Journal of Medicine, 1994
- High 10-year survival rate in patients with early, untreated prostatic cancerPublished by American Medical Association (AMA) ,1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- Stereological estimation of the volume‐weighted mean volume of arbitrary particles observed on random sections*Journal of Microscopy, 1985
- Particle sizes and their distributions estimated from line‐ and point‐sampled intercepts. Including graphical unfoldingJournal of Microscopy, 1983